Q4 2023 · 13F-HR
Novo Holdings A/Sholdings as filed
Filed 2024-02-14 · accession 0000950123-24-002161
$1.62B
Reported value
36
Positions
2023-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 11271J107 | BN | BROOKFIELD CORP | $155.7M | 9.61% | 3,880,230 | Common | SOLE |
| N07059210 | ASML | ASML HOLDING N V | $149.7M | 9.24% | 197,760 | Common | SOLE |
| 79466L302 | CRM | SALESFORCE.COM, INC. | $139.6M | 8.62% | 530,500 | Common | SOLE |
| 84833T103 | SPRO | SPERO THERAPEUTICS INC | $123.4M | 7.62% | 468,902 | Common | SOLE |
| 51655R101 | — | LANZATECH GLOBAL INC | $79.5M | 4.91% | 15,814,845 | Common | SOLE |
| 218352102 | CORT | CORCEPT THERAPEUTICS INC | $78.3M | 4.84% | 2,411,362 | Common | SOLE |
| 874039100 | TSM | TAIWAN SEMICONDUCTOR MFG LTD | $73.9M | 4.56% | 710,780 | Common | SOLE |
| 28036F105 | EWTX | EDGEWISE THERAPEUTICS INC | $66.4M | 4.10% | 6,071,703 | Common | SOLE |
| 12685J105 | CABO | CABLE ONE INC | $65.9M | 4.07% | 118,403 | Common | SOLE |
| 92243G108 | PCVX | VAXCYTE INC | $53.1M | 3.28% | 845,000 | Common | SOLE |
| 604749101 | MIRM | MIRUM PHARMACEUTICALS INC | $44.3M | 2.73% | 1,500,000 | Common | SOLE |
| 09061G101 | BMRN | BIOMARIN PHARMACEUTICAL INC | $43.4M | 2.68% | 450,000 | Common | SOLE |
| N69605108 | PHVS | PHARVARIS N V | $43.2M | 2.67% | 1,539,325 | Common | SOLE |
| 037833100 | AAPL | APPLE INC | $42.6M | 2.63% | 221,460 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $41.5M | 2.56% | 1,339,304 | Common | SOLE |
| 22663K107 | CRNX | CRINETICS PHARMACEUTICALS IN | $39.1M | 2.42% | 1,100,000 | Common | SOLE |
| 01609W102 | BABA | ALIBABA GROUP HLDG LTD | $38.8M | 2.40% | 500,827 | Common | SOLE |
| 03152W109 | AM6 | AMICUS THERAPEUTICS INC | $35.5M | 2.19% | 2,500,000 | Common | SOLE |
| 09627Y109 | 2655787D | BLUEPRINT MEDICINES CORP | $33.1M | 2.05% | 359,126 | Common | SOLE |
| 77313F106 | RCKT | ROCKET PHARMACEUTICALS INC | $31.5M | 1.94% | 1,050,000 | Common | SOLE |
| 35104E100 | FDMT | 4D MOLECULAR THERAPEUTICS IN | $30.4M | 1.88% | 1,500,000 | Common | SOLE |
| 14179K101 | CRGX | CARGO THERAPEUTICS INC | $28.9M | 1.79% | 1,250,000 | Common | SOLE |
| 92539P101 | — | VERVE THERAPEUTICS INC | $27.9M | 1.72% | 2,000,000 | Common | SOLE |
| 113004105 | BAM | BROOKFIELD ASSET MANAGMT LTD | $25.2M | 1.56% | 627,207 | Common | SOLE |
| 02043Q107 | ALNY | ALNYLAM PHARMACEUTICALS INC | $22.7M | 1.40% | 118,383 | Common | SOLE |
| 23257D103 | CBAYUSD | CYMABAY THERAPEUTICS INC | $21.3M | 1.31% | 900,000 | Common | SOLE |
| 85209E109 | — | SPRUCE BIOSCIENCES INC | $19.7M | 1.22% | 6,722,336 | Common | SOLE |
| 52886X107 | LXEO | LEXEO THERAPEUTICS INC | $17.6M | 1.08% | 1,307,829 | Common | SOLE |
| 457730109 | INSP | INSPIRE MED SYS INC | $13.3M | 0.82% | 65,524 | Common | SOLE |
| 449778109 | IOBTQ | IO BIOTECH INC | $10.8M | 0.67% | 5,747,067 | Common | SOLE |
| 00288U106 | ABCL | ABCELLERA BIOLOGICS INC | $6.4M | 0.40% | 1,126,915 | Common | SOLE |
| 89455T109 | TMCI | TREACE MED CONCEPTS INC | $4.6M | 0.28% | 360,000 | Common | SOLE |
| 75120L100 | — | RALLYBIO CORP | $4.2M | 0.26% | 1,767,861 | Common | SOLE |
| 57142B104 | MQ | MARQETA INC | $3.1M | 0.19% | 441,558 | Common | SOLE |
| N51517105 | 4PKB | LAVA THERAPEUTICS NV | $3.0M | 0.18% | 1,878,194 | Common | SOLE |
| 36322Q107 | GLTOUSD | GALECTO INC | $1.8M | 0.11% | 2,497,791 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.